Nealon, Joshua Alexander Patrick

Research Assistant Professor

Division of Epidemiology and Biostatistics

  • BSc, MSc, PhD
Dr. Nealon joined the School of Public Health in 2022. He was originally trained in Medical Microbiology at the University of Edinburgh before working for a startup company associated with the Chemical Pathology Department of the Chinese University of Hong Kong, using molecular biomarkers of fetal-maternal disorders. Joshua completed a Masters at the London School of Hygiene and Tropical Medicine in 2005 and after graduating, he worked for the World Health Organization in Cambodia conducting operataional research on the prevention of dengue through vector control and community engagement. He subsequently took a regional role for WHO in Manila, forcussing on the prevention and control of vector-borne diseases in the context of climate change. After that, he worked for Sanofi Pasteur – a global vaccine company – with responsibility for the epidemiology of vaccine preventable diseases including dengue, Japanese encephalitis and influenza, leading the data generation associated with launching innovative vaccines in developing and developed countries. Joshua completed his PhD in Epidemiology at the Univeristy of Edinburgh in 2021 and his research interests include the broader medical complications of infectous diseases, vaccine effectiveness studies and novel methods of conducting them.
Selected Publications
  1. Nealon J, Modin D, Ghosh R, et al. The feasibility of large, pragmatic, influenza vaccine randomized controlled trials using non-specific endpoints: exploring real world data from Denmark and England. NPJ Vaccines 2022 [in press].
  2. Taniguchi K, Ikeda S, Hagiwara Y, … Nealon J. Epidemiology and burden of illness of seasonal influenza among the elderly in Japan: A systematic literature review and vaccine effectiveness meta‐analysis. Influenza Other Respi Viruses. 2021;15(2):293-314.
  3. Ylade M, Agrupis KA, Daag JV, … Nealon J, et al. Effectiveness of a single-dose mass dengue vaccination in Cebu, Philippines: A case-control study. Vaccine. 2021;39(37):5318-5325.
  4. Nealon J, Bouckenooghe A, Cortes M, et al. Dengue endemicity, force of infection and variation in transmission intensity in 13 endemic countries. J Infect Dis. Published online March 25, 2020. [IF: 5.022, ranked 11/93 under the category “Science: Infectious diseases”]
  5. Macias AE, Mcelhaney JE, Chaves SS, Nealon J, et al. The disease burden of influenza beyond respiratory illness. Vaccine. 2020; 39; A6 – A14.
  6. Bhavsar A, Tam CC, Garg S, … Nealon J. Estimated dengue force of infection and burden of primary infections among Indian children. BMC Public Health. 2019;19(1):1116.
  7. Nealon J, Lim W-Y, Moureau A, et al. Feasibility of case-control and test-negative designs to evaluate dengue vaccine effectiveness in Malaysia. Vaccine. 2019;37(39):5891-5898.
  8. Nealon J, Taurel A-F, Yoksan S, et al. Serological Evidence of Japanese Encephalitis Virus Circulation in Asian Children From Dengue-Endemic Countries. J Infect Dis. 2019;219(3). [IF: 5.022, ranked 11/93 under the category “Science: Infectious diseases”]
  9. Garg S, Chakravarti A, Singh R ,… Nealon J.  Dengue serotype-specific seroprevalence among 5- to 10-year-old children in India: a community-based cross-sectional study. Int J Infect Dis. 2017;54. [IF: 3.623, ranked 45/ 92 under the category “Infectious Diseases"]
  10. Wahyono TYM, Nealon J, Beucher S, et al. Indonesian dengue burden estimates: Review of evidence by an expert panel. Epidemiol Infect. 2017;145(11). [IF: 2.152, ranked 50/93 under the category “Epidemiology”]
  11. Ebi KL, Nealon J. Dengue in a changing climate. Environ Res. 2016;151:115-123.
  12. Nealon J, Taurel A, Capeding MR, et al. Symptomatic Dengue Disease in Five Southeast Asian Countries: Epidemiological Evidence from a Dengue Vaccine Trial. PLoS Negl Trop Dis. 2016;10(8):e0004918.